SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE

LA JOLLA, CA

Oncologysmall moleculeGrant-only

Compare Sign in to watch

What changed

NIH R01 · $0.8M · Screening for Inhibitors of the Chromatin Reader SGF29

Apr 2025New grantApr 8, 2025Source filing (opens the source filing in a new tab)

Momentum

34no change

Little recent filing activity, or the events on file have decayed.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

Grant
R01 · $768k · non-dilutive
Apr 8, 2025
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI DESHPANDE, ANIRUDDHA J. · NCI · award ends Mar 31, 2028 · Screening for Inhibitors of the Chromatin Reader SGF29
NIH RePORTER · NIH RePORTER 11168638 (opens the source filing in a new tab)
Grant
R01 · $699k · non-dilutive
Apr 10, 2023
VIRGINIA COMMONWEALTH UNIVERSITY · PI RADHAKRISHNAN, SENTHIL KUMAR · NCI · award ends Mar 31, 2027 · Identification of small molecule inhibitors of the DDI2 protease
NIH RePORTER · NIH RePORTER 11057516 (opens the source filing in a new tab)
Grant
R01 · $449k · non-dilutive
Apr 12, 2022
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI DESHPANDE, ANIRUDDHA J. · NCI · award ends Mar 31, 2027 · Molecular Pathogenesis of AF10-Rearranged Leukemias
NIH RePORTER · NIH RePORTER 11055387 (opens the source filing in a new tab)

How this crosswalk was built

Confidence 58%Edges merged automatically, not yet reviewed by a human

Shared principal investigator or founder links the grant record at 0.78name similarity 100% · shared principal investigator / founder · same city · same therapeutic area
Shared principal investigator or founder links the grant record at 0.75grant to an academic institution linked by a shared principal investigator

Links score at or above 0.86 to merge automatically. Anything below that and above the review line goes to a human queue. Resolution is a judgment, and it can be wrong. How resolution works.

Event stream

Every scored event, newest first. This is what momentum is computed from.

NIH R01 · $0.8M · Screening for Inhibitors of the Chromatin Reader SGF29
Apr 2025New grantSource (opens the source filing in a new tab)
NIH R01 · $0.4M · Molecular Pathogenesis of AF10-Rearranged Leukemias
Mar 2025Grant renewalSource (opens the source filing in a new tab)
NIH R01 · $0.7M · Identification of small molecule inhibitors of the DDI2 protease
Mar 2025Grant renewalSource (opens the source filing in a new tab)

Last disclosed raise

No Form D is on file, so there is no raise to model a runway from. That is why the runway reads “—” rather than a number. It does not mean the company has no money: grants, revenue and notes below the Form D threshold are all invisible here.

Something wrong on this page? The crosswalk is a judgment and we would rather hear it. Report a bad link.

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources

Grant to raise

R01 · $768k · non-dilutive

R01 · $699k · non-dilutive

R01 · $449k · non-dilutive